TORONTO--(BUSINESS WIRE)--April 21, 2008--Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that Bill Bristow has tendered his resignation from the Company's Board of Directors, effective immediately, due to his ongoing personal relationship with Eugene Melnyk.
The Compensation, Nominating and Governance Committee of the Board of Directors continues to search for qualified new members to add further independent expertise to the Board. Biovail anticipates making an announcement in this regard in the near term.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
CONTACT: Biovail Corporation Nelson F. Isabel,
905-286-3000 Vice-President,
Investor Relations and Corporate Communications
